Safety and efficacy of upadacitinib in patients refractory to nonbiologic DMARDsMay 3, 2021Psoriatic Arthritis
Rheumatology NewsPsoriasis associated with an increased risk of COVID-19 in real-world studyApril 28, 2021COVID-19 UpdatesPsoriatic Arthritis
Rheumatology NewsDebate: Should biologics be used for milder cases of psoriasis?April 26, 2021Psoriatic Arthritis
Rheumatology NewsBoosting the presence of darker skin in rheumatology educationApril 21, 2021Diversity in MedicineLupus & Connective Tissue DiseasesPsoriatic ArthritisPediatricsRheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitis
Rheumatology NewsMost patients with chronic inflammatory diseases have sufficient response to COVID-19 vaccinationApril 20, 2021COVID-19 UpdatesAnkylosing spondylitisLupus & Connective Tissue DiseasesPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Rheumatology NewsRheumatology clinics find success with smoking cessation referral programApril 8, 2021Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesGoutAnkylosing spondylitis
Rheumatology NewsResearchers stress importance of second COVID-19 vaccine dose for infliximab usersApril 6, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Rheumatology NewsBimekizumab superior to adalimumab in head-to-head psoriasis studyApril 6, 2021Psoriatic Arthritis
Over half of PsA patients not diagnosed within 2 years of symptom onsetApril 5, 2021Psoriatic Arthritis
Agreement between modalities for imaging of finger joints in PsA patientsApril 5, 2021Psoriatic Arthritis
Intravenous golimumab improves HRQoL and productivity in patients with active PsAApril 5, 2021Psoriatic Arthritis
Depression and anxiety linked to reduced probability of achieving sustained MDA in PsAApril 5, 2021Psoriatic Arthritis
Risk factors for progression from subclinical to clinical psoriatic arthritisApril 5, 2021Psoriatic Arthritis
